Article Text

PDF

Vigabatrin in the treatment of epilepsy: a long-term follow-up study.
  1. A Tartara,
  2. R Manni,
  3. C A Galimberti,
  4. J P Mumford,
  5. A Iudice,
  6. E Perucca
  1. Institute of Neurology C. Mondino, University of Pavia, Italy.

    Abstract

    Twenty-five adult epileptic patients who had shown a satisfactory clinical response to add-on vigabatrin under placebo-controlled conditions continued on long-term treatment for up to 47 months (median 22 months). The initially favourable therapeutic response was generally maintained throughout the observation period with an overall good clinical tolerance. No evidence of neurotoxicity was detected by multimodal evoked potentials monitoring.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.